OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	28
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	27
Editorial introductions	27
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	26
Maximizing opportunities for kidney transplantation in older adults	24
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	21
Dual organ transplantation: Pancreas and Liver in the kidney axis	20
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	19
The clinical application of frailty in nephrology and transplantation	19
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	18
Interferon gamma in the pathogenesis of hypertension − recent insights	18
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	18
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	17
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	17
International equity in access to home dialysis	15
Prediction models for earlier stages of chronic kidney disease	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	14
Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population	14
Modern indications for referral for kidney and pancreas transplantation	14
Editorial introduction	14
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	13
Bringing the end-stage kidney disease life plan home	13
Renal denervation for the treatment of hypertension and kidney disease	13
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	12
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	12

Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	12
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	11
Plant-based diets for kidney disease prevention and treatment	11
The race coefficient in glomerular filtration rate-estimating equations and its removal	10
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	10
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	10
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	10
Built environment and chronic kidney disease: current state and future directions	10
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	10
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Understanding renal phosphate handling: unfinished business	9
Editorial: One size does not fit all: moving toward individualized therapy	9
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	9
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	9
Complement detection in kidney biopsies – utility and challenges	9
Cancer drugs and acute kidney injury: new therapies and new challenges	8
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	8
Noninvasive continuous intradialytic blood pressure monitoring: the key to improving haemodynamic stability	8
Editorial: Advancements in the management of kidney disease and electrolyte derangements	8
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	8
Lipocalin-2: a novel link between the injured kidney and the bone	8
Climate change and kidney stones	8
Advances in management of hepatorenal syndrome	8
Editorial introductions	8
Deep learning applications for kidney histology analysis	7
The current therapeutic approach for anaemia after kidney transplant	7
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	7
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	7
HIV-associated kidney disease: the changing spectrum and treatment priorities	7
Impact of intensive blood pressure control on kidney outcomes	7
Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice	7
Recent advances in dialysis membranes	7
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	7
Automation and innovation in home hemodialysis machines	7
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	7
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	7
New insights into renal calcium-sensing receptor activation	7
Hypernatremia in the intensive care unit	6
New and old approaches to nutritional management of acute and chronic glomerulonephritis	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Contemporary risk prediction models in chronic kidney disease: when less is more	6
Editorial introductions	6
Evolving thresholds for the diagnosis of acute T cell mediated rejection	6
Renal osteodystrophy: something old, something new, something needed	6
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Renal denervation: recent developments in clinical and preclinical research	6
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	6
Sex differences in renal electrolyte transport	6
Editorial introduction	6

Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Prospects for gene therapy in polycystic kidney disease	6
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	5
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	5
Evolving indications and management patterns in heart – kidney transplantation	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
Novel approaches in antihypertensive pharmacotherapeutics	5
Screening for chronic kidney disease: change of perspective and novel developments	5
Editorial introductions	5
Novel intestinal dialysis interventions and microbiome modulation to control uremia	5
The genetics of cystinuria – an update and critical reevaluation	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
Building kidney organoids from pluripotent stem cells	5
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
The changing trajectory of diabetic kidney disease	5
Editorial: A humble way forward amid hype and hope	5